Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Abstract Background We aimed to clarify the benefits of the addition of rh‐endostatin into concurrent chemoradiotherapy (CCRT) versus CCRT alone for locally advanced non‐small cell lung cancer (NSCLC) by a meta‐analysis. Methods PubMed, Embase, Cochrane Central Register of Controlled Trials, Wanfang...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meng Yuan, Yirui Zhai, Yu Men, Jianyang Wang, Lei Deng, Wenqing Wang, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Yunsong Liu, Jun Wang, Hui Zhu, Zhouguang Hui
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
chemoradiotherapy
endostar
meta‐analysis
NSCLC
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/a597e61c70d744ec9bc1c2305f16b691
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a597e61c70d744ec9bc1c2305f16b691

Ejemplares similares